Kronox Lab Sciences Limited (KRONOX) AI Stock Analysis

Kronox Lab Sciences Limited

(NSE:KRONOX)

Select Model

Rating:82Outperform

Price Target:INR 250.00▲(28.61% Upside)

Action:reiterated

Date:08/26/26

The stock’s high score is driven primarily by very strong financial fundamentals, including robust profitability, a low‑leverage balance sheet, and solid cash generation, supporting quality and resilience. Positive price momentum above all key moving averages further reinforces the outlook. The main offset is a valuation that embeds a reasonable premium and a very low dividend yield, which keeps the score in the low 80s rather than at the top of the range.

Positive Factors

ProfitabilityRising net income alongside strong gross, EBIT, and net margins indicates effective operating economics and sustained profitability. This earnings base can support reinvestment and strengthen financial resilience over the next several quarters, even if revenue growth remains modest.

Negative Factors

Limited Revenue GrowthNear-flat reported revenue suggests that the company’s top-line expansion is currently limited. Even with strong profitability, weak sales growth can constrain operating leverage, reduce reinvestment opportunities, and make future earnings growth more dependent on efficiency gains.

Kronox Lab Sciences Limited (KRONOX) vs. iShares MSCI India ETF (INDA)

Market Cap: INR 7.05B
Dividend Yield: 0.27%
Average Volume (3M): 62.11K
Price to Earnings (P/E): 24.1
Beta (1Y): 1.23
Revenue Growth: 6.07%
EPS Growth: 11.62%
Country: India
Employees: 70
Sector: General
Sector Strength: 55
Industry: Chemicals - Specialty

Kronox Lab Sciences Limited Business Overview & Revenue Model

Company Description

Kronox Lab Sciences Ltd. operates as a manufacturer and global supplier of a diverse range of chemical products, encompassing fine chemicals, inorganic compounds, phosphates, and metallic chemicals, serving markets both within India and worldwide. It...

Kronox Lab Sciences Limited Financial Statement Overview

Summary

Strong profitability, an almost debt‑free and growing equity-rich balance sheet, and solid though slightly softer free cash flow support a high score, with only the recent slowdown in revenue and dip in free cash flow growth as watchpoints.

Income Statement

86Very Positive

Balance Sheet

93Very Positive

Cash Flow

78Positive

Financial statement breakdown
Breakdown	TTM	Mar 2025	Mar 2024	Mar 2024	Mar 2023	Mar 2022
Income Statement
Total Revenue	992.88M	1.01B	898.62M	1.00B	955.78M	822.47M
Gross Profit	499.82M	546.44M	440.05M	492.71M	406.96M	348.47M
EBITDA	358.54M	394.65M	298.97M	356.53M	239.16M	207.89M
Net Income	255.96M	276.60M	213.51M	254.67M	166.17M	136.27M
Balance Sheet
Total Assets	0	1.28B	739.94M	988.26M	540.34M	567.88M
Cash, Cash Equivalents and Short-Term Investments	358.73M	487.41M	149.18M	358.73M	56.47M	100.04M
Total Debt	0	16.07M	0	0	0	33.60M
Total Liabilities	-901.05M	113.96M	76.89M	87.22M	92.83M	164.35M
Stockholders Equity	901.05M	1.16B	663.05M	901.05M	446.79M	403.53M
Cash Flow
Free Cash Flow	155.63M	205.85M	51.45M	275.92M	112.50M	52.24M
Operating Cash Flow	164.11M	238.93M	174.15M	306.97M	196.65M	90.20M
Investing Cash Flow	-155.27M	-238.20M	-173.12M	-283.94M	-55.17M	-75.99M
Financing Cash Flow	17.00K	-3.62M	0	-18.54M	-133.96M	-6.66M

Kronox Lab Sciences Limited Technical Analysis

Technical Analysis SentimentNeutral

Last Price194.38

Price Trends

50DMA192.11Negative

100DMA172.18Positive

200DMA148.87Positive

Market Momentum

MACD-0.11Positive

RSI44.35Neutral

STOCH36.00Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:KRONOX, the sentiment is Neutral. The current price of 194.38 is below the 20-day moving average (MA) of 201.19, above the 50-day MA of 192.11, and above the 200-day MA of 148.87, indicating a neutral trend. The MACD of -0.11 indicates Positive momentum. The RSI at 44.35 is Neutral, neither overbought nor oversold. The STOCH value of 36.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:KRONOX.

Kronox Lab Sciences Limited Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

IN:KRONOX against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
IN:KRONOX	82Outperform	INR 6.98B	24.06	―	0.27%	6.07%	11.62%
IN:DICIND	76Outperform	INR 4.99B	16.36	―	0.55%	11.71%	79.88%
IN:CHEMBOND	61Neutral	INR 2.38B	15.88	―	1.12%	0.83%	-34.03%
IN:PODDARMENT	60Neutral	INR 2.79B	18.11	―	1.53%	3.55%	-21.35%
IN:ASAHISONG	59Neutral	INR 4.36B	12.53	―	0.41%	-0.60%	96.35%
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
IN:MANORG	38Underperform	INR 3.81B	18.59	―	―	17.28%	-10.19%

* General Sector Average

Performance Comparison

IN:KRONOX and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
IN:KRONOX	Kronox Lab Sciences Limited	188.10	42.02	28.77%
IN:ASAHISONG	Asahi Songwon Colors Ltd.	370.00	86.70	30.60%
IN:CHEMBOND	Chembond Chemicals Limited	176.85	7.19	4.24%
IN:DICIND	DIC India Limited	544.00	28.87	5.60%
IN:MANORG	Mangalam Organics Ltd	445.00	-66.40	-12.98%
IN:PODDARMENT	Poddar Pigments Limited	262.80	-8.53	-3.14%

Kronox Lab Sciences Limited Corporate Events

Kronox Lab Sciences Sets September Date for 17th AGM via Virtual Format

Aug 30, 2026

Kronox Lab Sciences Limited operates in the laboratory chemicals and scientific supplies sector, serving industrial and research clients through its portfolio of high-purity reagents and related lab products. The company is listed on both the Nationa...

Kronox Lab Sciences Sets September 16 AGM, Proposes Dividend and Cost Audit Pay

Aug 24, 2026

Kronox Lab Sciences Limited has scheduled its 17th Annual General Meeting for September 16, 2026, at 11:00 a.m., to be conducted via video conferencing and other audio-visual means in line with recent regulatory guidance. The company has circulated t...

Indo Borax launches open offer for public shareholders of Kronox Lab Sciences

Aug 21, 2026

Kronox Lab Sciences Limited has disclosed that it has received a public announcement for an open offer to its public shareholders, triggered under India’s takeover regulations. The offer is being made by Indo Borax & Chemicals Limited, toge...

Kronox Promoters Agree to Sell Majority Stake to Indo Borax

Aug 20, 2026

Promoters of Kronox Lab Sciences Limited have signed a share purchase agreement to sell 2,38,44,000 equity shares, representing about 64.26% of the company’s paid-up equity capital, to Indo Borax & Chemicals Limited, with Zenrock Chemicals...

Kronox Lab Sciences Publishes Q1 FY2026 Unaudited Results in Newspapers

Aug 16, 2026

Kronox Lab Sciences Limited has notified the National Stock Exchange of India and BSE that it has published its unaudited financial results for the quarter ended June 30, 2026 in the Indian Express and Financial Express newspapers. The disclosure, ma...

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Aug 26, 2026

Kronox Lab Sciences Limited AI Stock Analysis